{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:09:54Z","timestamp":1782788994553,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["AGM-12006"],"award-info":[{"award-number":["AGM-12006"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["ACB-12002"],"award-info":[{"award-number":["ACB-12002"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30GM138396"],"award-info":[{"award-number":["P30GM138396"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK046335"],"award-info":[{"award-number":["DK046335"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL154732"],"award-info":[{"award-number":["HL154732"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD012289-01A1"],"award-info":[{"award-number":["1S10OD012289-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016958","name":"Office of Research Infrastructure Programs, National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD012289-01A1"],"award-info":[{"award-number":["1S10OD012289-01A1"]}],"id":[{"id":"10.13039\/100016958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bmcl.2022.128571","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T18:21:25Z","timestamp":1642616485000},"page":"128571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Amyloidogenic immunoglobulin light chain kinetic stabilizers comprising a simple urea linker module reveal a novel binding sub-site"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-550X","authenticated-orcid":false,"given":"Nicholas L.","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0234-7628","authenticated-orcid":false,"given":"Reji","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0788-7217","authenticated-orcid":false,"given":"Kristen A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1275-2010","authenticated-orcid":false,"given":"Gareth J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8943-3395","authenticated-orcid":false,"given":"Jeffery W.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2022.128571_b0005","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2022.128571_b0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/17474086.2014.858594","article-title":"Immunoglobulin light chain amyloidosis","volume":"7","author":"Merlini","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.bmcl.2022.128571_b0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.bmcl.2022.128571_b0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bpc.2017.08.011","article-title":"Kinetic stability and sequence\/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients","volume":"230","author":"Blancas-Mej\u00eda","year":"2017","journal-title":"Biophys Chem"},{"key":"10.1016\/j.bmcl.2022.128571_b0025","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1016\/j.jmb.2016.08.021","article-title":"The kinetic stability of a full-length antibody light chain dimer determines whether endoproteolysis can release amyloidogenic variable domains","volume":"428","author":"Morgan","year":"2016","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmcl.2022.128571_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100334","article-title":"Molecular mechanism of amyloidogenic mutations in hypervariable regions of antibody light chains","volume":"296","author":"Rottenaicher","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2022.128571_b0035","doi-asserted-by":"crossref","first-page":"eaax0914","DOI":"10.1126\/scitranslmed.aax0914","article-title":"Does protein aggregation drive postmitotic tissue degeneration?","volume":"13","author":"Kelly","year":"2021","journal-title":"Sci Trans Med"},{"key":"10.1016\/j.bmcl.2022.128571_b0040","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1182\/blood-2011-11-390930","article-title":"Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis","volume":"119","author":"Mikhael","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bmcl.2022.128571_b0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/cells10030545","article-title":"Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis","volume":"10","author":"Palladini","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bmcl.2022.128571_b0050","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38\u03b1 MAPK pathway","volume":"107","author":"Shi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmcl.2022.128571_b0055","doi-asserted-by":"crossref","first-page":"H95","DOI":"10.1152\/ajpheart.00186.2013","article-title":"Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish","volume":"305","author":"Mishra","year":"2013","journal-title":"Am J Physiol - Heart Circ Physiol"},{"key":"10.1016\/j.bmcl.2022.128571_b0060","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/circ.104.14.1594","article-title":"Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts","volume":"104","author":"Liao","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bmcl.2022.128571_b0065","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1073\/pnas.1817567116","article-title":"Stabilization of amyloidogenic immunoglobulin light chains by small molecules","volume":"116","author":"Morgan","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmcl.2022.128571_b0070","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1021\/acs.jmedchem.1c00339","article-title":"Discovery of potent coumarin-based kinetic stabilizers of amyloidogenic immunoglobulin light chains using structure-based design","volume":"64","author":"Yan","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2022.128571_b0075","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1006\/bbrc.1995.2416","article-title":"Galactose stabilizes various missense mutants of alpha-galactosidase in Fabry disease","volume":"214","author":"Okumiya","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmcl.2022.128571_b0080","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/molpharm.120.000180","article-title":"Identification of chemical and pharmacological chaperones for correction of trafficking-deficient mutant cyclic nucleotide-gated A3 channels","volume":"99","author":"T\u00e4ger","year":"2021","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmcl.2022.128571_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11020106","article-title":"Galactosemia: towards pharmacological chaperones","volume":"11","author":"Banford","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.bmcl.2022.128571_b0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fcell.2020.00271","article-title":"Small molecule chaperones for the treatment of gaucher disease and GBA1-associated Parkinson disease","volume":"8","author":"Han","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.bmcl.2022.128571_b0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal \u03b1\u2013galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2022.128571_b0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ajh.24723","article-title":"Treatment patterns and outcome following initial relapse or refractory disease in patients with systemic light chain amyloidosis","volume":"92","author":"Tandon","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bmcl.2022.128571_b0105","doi-asserted-by":"crossref","first-page":"9629","DOI":"10.1073\/pnas.1121005109","article-title":"Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade","volume":"109","author":"Bulawa","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bmcl.2022.128571_b0110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.bmcl.2022.128571_b0115","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bmcl.2022.128571_b0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/jsbi.2000.4248","article-title":"Review: immunoglobulin light chain amyloidosis\u2013the archetype of structural and pathogenic variability","volume":"130","author":"Bellotti","year":"2000","journal-title":"J Struct Biol"},{"key":"10.1016\/j.bmcl.2022.128571_b0125","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2002-09-2707","article-title":"Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL)","volume":"101","author":"Abraham","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bmcl.2022.128571_b0130","doi-asserted-by":"crossref","first-page":"16809","DOI":"10.1038\/s41598-017-16953-7","article-title":"Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity","volume":"7","author":"Oberti","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2022.128571_b0135","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1021\/bi00715a031","article-title":"Binding of 2,4-dinitrophenyl compounds and other small molecules to a crystalline lambda-type Bence-Jones dimer","volume":"13","author":"Edmundson","year":"1974","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2022.128571_b0140","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/prot.340160304","article-title":"Principles and pitfalls in designing site-directed peptide ligands","volume":"16","author":"Edmundson","year":"1993","journal-title":"Proteins"},{"key":"10.1016\/j.bmcl.2022.128571_b0145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10935","article-title":"Inhibition by small-molecule ligands of formation of amyloid fibrils of an immunoglobulin light chain variable domain","volume":"4","author":"Brumshtein","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.bmcl.2022.128571_b0150","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.3390\/molecules26123571","article-title":"Barriers to small molecule drug discovery for systemic amyloidosis","volume":"26","author":"Morgan","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2022.128571_b0155","doi-asserted-by":"crossref","first-page":"14101","DOI":"10.1021\/bi991131j","article-title":"Thermodynamic instability of human \u03bb6 light chains: correlation with fibrillogenicity","volume":"38","author":"Wall","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmcl.2022.128571_b0160","doi-asserted-by":"crossref","first-page":"7062","DOI":"10.1002\/ejoc.201101117","article-title":"A mild titanium-catalyzed synthesis of functionalized amino coumarins as fluorescence labels","volume":"2011","author":"Wirtz","year":"2011","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmcl.2022.128571_b0165","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1021\/jo7015955","article-title":"Scope of the Suzuki\u2212Miyaura aminoethylation reaction using organotrifluoroborates","volume":"72","author":"Molander","year":"2007","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2022.128571_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127356","article-title":"Structural basis for the stabilization of amyloidogenic immunoglobulin light chains by hydantoins","volume":"30","author":"Yan","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2022.128571_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506120802676781","article-title":"AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences","volume":"16","author":"Bodi","year":"2009","journal-title":"Amyloid"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X22000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:21:36Z","timestamp":1778570496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X22000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":35,"alternative-id":["S0960894X22000476"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128571","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloidogenic immunoglobulin light chain kinetic stabilizers comprising a simple urea linker module reveal a novel binding sub-site","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2022.128571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128571"}}